| Lineage |
Neuron > Hyperactive |
| Markers |
c-Fos, Arc, Egr-1, p-CREB, DeltaFosB |
| Brain Regions |
Hippocampus, Cerebral Cortex, Basal Ganglia, Thalamus |
| Disease Relevance |
Epilepsy, Alzheimer's Disease, Autism Spectrum Disorder, Schizophrenia |
Hyperactive Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Hyperactive neurons represent a state of excessive electrical and computational activity that deviates significantly from physiological firing patterns. This hyperactivity can manifest as increased action potential frequency, abnormal burst firing, synchronized network oscillations, or pathological hyperexcitability [1]. While transient neuronal hyperactivity can serve important physiological functions including learning and memory consolidation, chronic hyperactivity is associated with numerous neurological and psychiatric disorders [2].
The phenomenon of neuronal hyperactivity was first described in the context of epilepsy, but subsequent research has revealed its importance in neurodegenerative diseases, neurodevelopmental disorders, and psychiatric conditions. Understanding the mechanisms underlying neuronal hyperactivity is crucial for developing targeted therapeutic interventions [3].
- Voltage-gated sodium channels: Nav1.1, Nav1.2 mutations cause familial epilepsy syndromes [4]
- Voltage-gated calcium channels: P/Q-type (Cav2.1) dysfunction leads to absent seizures [5]
- Voltage-gated potassium channels: KCNQ2/3 (M-channel) mutations cause benign familial neonatal seizures [6]
- Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels: Reduced HCN1 expression increases neuronal excitability [7]
- NMDA receptor dysfunction: Excessive NMDA receptor activity increases calcium influx and promotes hyperactivity [8]
- AMPA receptor trafficking: GluA2-lacking AMPA receptors increase excitability [9]
- Metabotropic glutamate receptors: Group I mGluRs (mGluR1/5) couple to neuronal excitation [10]
- cAMP/PKA pathway: Elevated cAMP levels enhance neuronal firing [11]
- MAPK/ERK pathway: Constitutive activation promotes hyperactivity [12]
- mTOR pathway: Dysregulated mTOR signaling causes hyperexcitability in tuberous sclerosis [13]
- Synaptic scaling: Impaired homeostatic synaptic downscaling fails to compensate for increased activity [14]
- Intrinsic plasticity: Failure of activity-dependent potassium conductance adaptations [15]
- Network-level homeostasis: Disrupted inhibitory interneuron function fails to restrain excitation [16]
- Increased firing frequency: Resting discharge rates elevated 2-10 fold [17]
- Burst firing: Pathological burst-pause patterns emerge [18]
- Depolarized resting membrane potential: Resting potential shifted 5-15 mV depolarized [19]
- Reduced spike frequency adaptation: Failure to adapt to sustained input [20]
- Increased excitatory synaptic drive: Elevated frequency and amplitude of EPSCs [21]
- Decreased inhibitory synaptic drive: Reduced IPSC amplitude and frequency [22]
- Impaired short-term plasticity: Abnormal facilitation and depression [23]
- Aberrant synaptic connectivity: Ectopic synapse formation [24]
- Hippocampal sclerosis: Hyperactive neurons in CA3 and dentate gyrus [25]
- Aberrant mossy fiber sprouting: Recurrent excitatory connections [26]
- Death of inhibitory interneurons: Loss of somatostatin and parvalbumin neurons [27]
- Balloon cells: Dysplastic neurons with altered excitability [28]
- mTOR pathway mutations: Cortical malformation with hyperexcitability [29]
- Layer 1 neuron hyperconnectivity: Enhanced excitatory networks [30]
- Pathological high-frequency oscillations: 80-200 Hz ripples precede seizures [31]
- Paroxysmal depolarizing shifts: Prolonged depolarizations with bursts [32]
- Gap junction coupling: Electrical coupling amplifies synchrony [33]
- Early hyperactivity: Hippocampal hyperactivity precedes amyloid deposition [34]
- Excitotoxicity: Excessive glutamate leads to calcium dysregulation [35]
- Network disruption: Hyperactive circuits exhibit abnormal oscillations [36]
- Direct neuronal effects: Aβ increases neuronal firing through various mechanisms [37]
- Synaptic dysfunction: Aβ enhances glutamatergic transmission [38]
- Plaque-associated hyperactivity: Surrounding neurons show increased activity [39]
- Hyperphosphorylated tau: Alters neuronal ion channel function [40]
- Tau spread: Hyperactive neurons more susceptible to tau pathology [41]
- Reduced GABAergic signaling: Decreased inhibitory neuron function [42]
- Enhanced glutamatergic signaling: Increased excitatory transmission [43]
- Genetic risk factors: Synaptic proteins with excitatory effects [44]
- Cortical hyperconnectivity: Excessive local excitation [45]
- Impaired gamma oscillations: Defective inhibitory timing [46]
- Sensory processing abnormalities: Hyperactive sensory cortices [47]
- Sodium channel blockers: Phenytoin, carbamazepine, lamotrigine [48]
- Calcium channel blockers: Ethosuximide for absence seizures [49]
- GABA enhancers: Benzodiazepines, valproate, phenobarbital [50]
- AMPA receptor antagonists: Perampanel for focal seizures [51]
- mTOR inhibitors: Everolimus for tuberous sclerosis [52]
- HCN channel modulators: Ivabradine for cardiac and neuronal hyperactivity [53]
- Potassium channel openers: Ezogabine reduces neuronal firing [54]
- Gene therapy: AAV-delivered channelrhodopsin for optogenetic control [55]
- Cell transplantation: GABAergic interneuron replacement [56]
- Deep brain stimulation: Responsive neurostimulation [57]
- Acute brain slices: 4-aminopyridine or picrotoxin-induced hyperactivity [58]
- Dissociated cultures: Potassium channel blockers [59]
- iPSC models: Patient-derived neurons with epilepsy mutations [60]
- Kindling models: Repeated seizures lower threshold [61]
- Genetic models: Scn1a knockout, Kcnq2 mutations [62]
- Chemoconvulsant models: PTZ, pilocarpine-induced seizures [63]
Hyperactive Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Hyperactive Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Stafstrom, C.E. (2006). Neuronal excitability in epilepsy. Epilepsia
- Noebels, J.L. (2003). The biology of epilepsy genes. Annual Review of Neuroscience
- Goldberg, E.M. & Coulter, D.A. (2013). Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nature Reviews Neuroscience
- Meisler, M.H. & Kearney, J.A. (2005). Sodium channel mutations in epilepsy and other neurological disorders. Journal of Clinical Investigation
- Pietrobon, D. (2010). CaV2.1 channelopathies. Pflugers Archiv European Journal of Physiology
- Jentsch, T.J. (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nature Reviews Neuroscience
- He, C. et al. (2014). HCN1 mutation causes cortical hyperexcitability and seizures. Annals of Neurology
- Traynelis, S.F. et al. (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacological Reviews
- Liu, S.J. & Zukin, R.S. (2007). Ca2+-permeable AMPA receptors in synaptic plasticity and neurological diseases. Trends in Neurosciences
- Niswender, C.M. & Conn, P.J. (2010). Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annual Review of Pharmacology and Toxicology
- Hille, B. (2001). Ion Channels of Excitable Membranes. Sinauer Associates
- Thomas, G.M. & Huganir, R.L. (2004). MAPK cascade signalling and synaptic plasticity. Nature Reviews Neuroscience
- Crino, P.B. (2011). mTOR: a pathogenic signaling pathway in developmental brain malformations. Lancet Neurology
- Turrigiano, G.G. (2000). Homeostatic plasticity in neuronal networks: the more things change, the more they stay the same. Trends in Neurosciences
- Desai, N.S. et al. (1999). Plasticity in the intrinsic excitability of cortical pyramidal neurons. Nature Neuroscience
- Huang, Z.J. et al. (2007). Activity-dependent development of inhibitory circuits. Nature Reviews Neuroscience
- Chrobak, J.J. & Buzsaki, G. (1996). High-frequency oscillations in the output networks of the hippocampal-entorhinal axis. Journal of Neuroscience
- Traub, R.D. & Wong, R.K. (1982). Cellular mechanism of neuronal synchronization in epilepsy. Science
- Bernard, C. et al. (2004). Acquired dendritic channelopathy in temporal lobe epilepsy. Science
- Madison, D.V. & Nicoll, R.A. (1984). Control of the repetitive discharge of rat CA1 pyramidal neurones in vitro. Journal of Physiology
- Mody, I. & MacDonald, J.F. (1995). NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Trends in Pharmacological Sciences
- Cossart, R. et al. (2005). Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy. Nature Neuroscience
- Zucker, R. & Regehr, W.G. (2002). Short-term synaptic plasticity. Annual Review of Physiology
- Ben-Ari, Y. (2008). Epilepsies: neonatal seizures. Nature Reviews Disease Primers
- Spencer, S.S. & Spencer, D.D. (1994). Entorhinal cortex contributions to temporal lobe epilepsy. Epilepsia
- Tauck, D.L. & Nadler, J.V. (1985). Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. Journal of Neuroscience
- de Lanerolle, N.C. et al. (2010). Aberrant hippocampal interneuron expression in human temporal lobe epilepsy. Brain Research
- Barkovich, A.J. et al. (2010). Classification system for malformations of cortical development. Brain
- Crino, P.B. (2015). The pathogenesis of malformations of cortical development. Neurobiology of Disease
- Lombardo, M.A. et al. (2018). Increased excitatory synaptic input to layer 2/3 pyramidal neurons in a mouse model of cortical dysplasia. Cerebral Cortex
- Jiruska, P. et al. (2013). High-frequency oscillations in human and animal epileptic tissues. Brain
- Gloor, P. (1978). Generalized epilepsy with spike-and-wave放电: neurophysiological mechanisms. Archives of Neurology
- Traub, R.D. et al. (2001). Model of gamma-frequency network dysrhythmia in CA1 hippocampal slices. Journal of Physiology
- Palop, J.J. & Mucke, L. (2010). Synaptic activity and compensatory plasticity in Alzheimer's disease. Nature Reviews Neuroscience
- Hynd, M.R. et al. (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochemistry International
- Busche, M.A. & Hyman, B.T. (2020). Synergy between amyloid-beta and tau in Alzheimer's disease. Nature Neuroscience
- Koh, M.T. et al. (2010). Amyloid-beta-induced neuronal hyperactivity in vivo. Nature Neuroscience
- Walsh, D.M. et al. (2002). Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature
- Spires-Jones, T.L. & Hyman, B.T. (2014). The intersection of amyloid beta and tau in Alzheimer's disease. Nature Reviews Neuroscience
- Liu, L. et al. (2012). Trans-synaptic spread of tau pathology in vivo. Cell
- Pooler, A.M. et al. (2013). Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Reports
- Rubenstein, J.L. & Merzenich, M.M. (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes, Brain and Behavior
- Nelson, S.B. & Valakh, V. (2015). Excitatory/inhibitory balance and circuit homeostasis in autism spectrum disorders. Neuron
- Gilman, S.R. et al. (2011). Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron
- Courchesne, E. et al. (2007). The ASD living biology: from cell proliferation to clinical phenotype. Molecular Psychiatry
- Uhlhaas, P.J. & Singer, W. (2006). Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology. Neuron
- Marco, E.J. et al. (2011). Sensory processing in autism: a review of neurophysiologic findings. Pediatric Research
- Rogawski, M.A. & Loscher, W. (2004). The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience
- Coulter, D.A. et al. (1989). Ethosuximide: mechanisms of action. Antiepileptic Drugs
- Olsen, R.W. & Avoli, M. (1997). GABA and epileptogenesis. Epilepsia
- Rogawski, M.A. & Hanada, T. (2013). Preclinical pharmacology of perampanel. Epilepsia
- Curatolo, P. & Moavero, R. (2012). mTOR inhibitors as a new therapeutic option for epilepsy. Expert Opinion on Therapeutic Targets
- Pape, H.C. (1996). Queer current and pacemaking: HCN channels in neuronal circuitry. Progress in Neurobiology
- Gunthorpe, M.J. et al. (2012). The progress of T-type Ca2+ channel blockers in the treatment of absence epilepsy. Channels
- Kokaia, M. et al. (2013). Non-viral gene therapy for spinal cord regeneration. Gene Therapy
- Tibbs, J.B. et al. (2016). Progress in cell-based therapies for epilepsy. Neurobiology of Disease
- Morrell, M.J. (2006). Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology
- Avoli, M. & Jefferys, J.G. (2005). Models of drug-induced epileptiform synchronization. Journal of Clinical Neurophysiology
- Bacci, A. et al. (2003). Block of GABA-receptor and potassium channels by picrotoxin in cultured hippocampal neurons. Brain Research
- Liu, Y. et al. (2013). Epilepsy-associated GRIN2A mutations reduce NMDA receptor trafficking and conductance. Human Molecular Genetics
- Goddard, G.V. (1967). Development of epileptic seizures through brain stimulation at low intensity. Nature
- Yu, F.H. et al. (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nature Neuroscience
- Turski, L. et al. (1983). Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behavioural Brain Research